Stocks Dynavax Technologies Corp

More

  • Jan 7- Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study, paving the way for the company to resubmit its marketing application. The earlier marketing application for the vaccine, HEPLISAV-B, was rejected in February 2013 by the U.S. Food and Drug Administration, which sought additional...

  • Jan 7- Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study, sending its shares up 9.4 percent in premarket trading. An earlier application was rejected by the FDA in February 2013. Dynavax's shares closed at $21.18 on the Nasdaq on Wednesday.

  • Jan 7- Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study. The company's shares were up 8.6 percent at $23 in premarket trading. The drug, HEPLISAV-B, was more effective than a currently marketed vaccine, Engerix-B, the drug developer said on Thursday.

  • Traders work on the floor of the New York Stock Exchange.
    JPMorgan's top stock picks for the second half

    In a note to clients Wednesday, JPMorgan issued a list of stocks the firm believes could provide excess returns in the second half of the year.

  • Mad Money Lightning Round
    Lightning Round: This was a 'one and done'

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Jim Cramer on the set of Mad Money
    Cramer Remix: I'm making a call on oil unrest

    “Mad Money” host Jim Cramer is eyeing the Middle East’s impact on oil.

  • blood tests
    Best biotech trades on ASH meeting: Kensho

    Three small-cap drug firms are consistently the best biotech performers following the start of the American Society of Hematology's annual meeting.

  • Mad Money Lightning Round
    Lightning Round: You're playing with fire

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Lightning Round: Markwest Energy, Bank of America & More
    Lightning Round: Coinstar, Lockheed Martin & More

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Lightning Round: Ford, Sirius XM, Intel & More

    Cramer makes the call on viewer favorites.

  • analyst_monitors_200.jpg
    10 Stocks Boosting Little Funds to Big Returns

    There are a handful of small, actively managed mutual funds holding little more than a dozen or so stocks boasting returns above 22 percent this year. Their secret? Old-fashioned stock picking of lesser-known or undervalued companies.

  • Winterizing Your Portfolio - A CNBC Special Report
    Stocks Erase Gains as Bank Fears Rattle Market

    Stocks erased their gains just in time for the closing bell Tuesday as news that the Senate has scheduled a hearing on President Obama's bank proposal for next week rattled the market.

  • Winterizing Your Portfolio - A CNBC Special Report
    Confidence Lifts Stocks; Travelers Leads Dow

    Stocks bounced back Tuesday after a report showed consumer confidence rose for a third straight month.  Travelers led the Dow after beating earnings expectations.

  • Winterizing Your Portfolio - A CNBC Special Report
    Stocks Rebound After Confidence Boost

    Stocks bounced back Tuesday after a report showed consumer confidence rose for a third straight month.  Travelers led the Dow after beating earnings expectations.

  • Winterizing Your Portfolio - A CNBC Special Report
    Futures Off Lows on Earnings Strength

    U.S. stock index futures indicated a lower open for Wall Street Tuesday, with stock markets in Asia and Europe knocked down by news of monetary tightening in China.

  • Biotechnology company MedImmune said it expects to report first-quarter earnings nearly tripled from a year earlier, helped by higher sales of its respiratory drug Synagis.